FUSN Insider Trading

Insider Ownership Percentage: 7.79%
Insider Buying (Last 12 Months): $90,132.00
Insider Selling (Last 12 Months): $517,191.81

Fusion Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Fusion Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fusion Pharmaceuticals Share Price & Price History

Current Price: $2.36
Price Change: Price Increase of +0.09 (3.96%)
As of 12/5/2022 01:00 AM ET

This chart shows the closing price history over time for FUSN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Fusion Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2022Steven GannonDirectorBuy44,400$2.03$90,132.0056,400View SEC Filing Icon  
4/27/2022John ValliantCEOSell4,511$6.03$27,201.33318,147View SEC Filing Icon  
4/25/2022John ValliantCEOSell2,036$6.03$12,277.08324,805View SEC Filing Icon  
4/20/2022John ValliantCEOSell367$6.02$2,209.34327,763View SEC Filing Icon  
4/13/2022John ValliantCEOSell11,994$6.41$76,881.54328,130View SEC Filing Icon  
4/11/2022John ValliantCEOSell2,600$7.37$19,162.00358,379View SEC Filing Icon  
4/8/2022John ValliantCEOSell826$7.52$6,211.52360,979View SEC Filing Icon  
4/6/2022John ValliantCEOSell100$7.58$758.00360,979View SEC Filing Icon  
3/30/2022John ValliantCEOSell300$7.52$2,256.00View SEC Filing Icon  
3/28/2022John ValliantCEOSell9,600$7.55$72,480.00View SEC Filing Icon  
3/25/2022John ValliantCEOSell500$7.42$3,710.00View SEC Filing Icon  
3/23/2022John ValliantCEOSell100$7.50$750.00View SEC Filing Icon  
3/21/2022John ValliantCEOSell1,500$7.47$11,205.00View SEC Filing Icon  
3/17/2022John ValliantCEOSell900$7.51$6,759.00View SEC Filing Icon  
3/7/2022John ValliantCEOSell3,100$6.99$21,669.00View SEC Filing Icon  
3/4/2022John ValliantCEOSell8,400$7.32$61,488.00View SEC Filing Icon  
2/28/2022John ValliantCEOSell3,100$7.40$22,940.00View SEC Filing Icon  
2/24/2022John ValliantCEOSell2,500$7.41$18,525.00View SEC Filing Icon  
2/22/2022John ValliantCEOSell4,100$7.85$32,185.00View SEC Filing Icon  
2/17/2022John ValliantCEOSell1,700$7.98$13,566.00View SEC Filing Icon  
2/15/2022John ValliantCEOSell12,600$8.33$104,958.00View SEC Filing Icon  
8/23/2021Steven GannonDirectorBuy2,829$7.99$22,603.7112,000View SEC Filing Icon  
8/16/2021Steven GannonDirectorBuy6,000$8.10$48,600.006,000View SEC Filing Icon  
12/23/2020Adams Street Partners LlcMajor ShareholderSell4,569$12.39$56,609.91View SEC Filing Icon  
6/30/2020Johnson & JohnsonMajor ShareholderBuy725,000$17.00$12,325,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Fusion Pharmaceuticals (NASDAQ:FUSN)

64.21% of Fusion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FUSN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Fusion Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Federated Hermes Inc.3,174,100$9.56M0.0%+1.6%7.091%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC28,494$86K0.0%N/A0.064%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.310,068$0.93M0.0%-5.7%0.693%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC16,800$51K0.0%N/A0.038%Search for SEC Filing on Google Icon
11/14/2022RA Capital Management L.P.659,992$1.99M0.0%N/A1.474%Search for SEC Filing on Google Icon
11/14/2022UBS Oconnor LLC17,286$52K0.0%N/A0.039%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG54,904$0.17M0.0%+167.1%0.127%Search for SEC Filing on Google Icon
11/8/2022Sofinnova Investments Inc.117,099$0.35M0.0%+50.0%0.270%Search for SEC Filing on Google Icon
11/4/2022Prudential Financial Inc.14,600$44K0.0%N/A0.034%Search for SEC Filing on Google Icon
11/2/2022Victory Capital Management Inc.50,390$0.15M0.0%-72.2%0.116%Search for SEC Filing on Google Icon
11/1/2022Tekla Capital Management LLC101,931$0.61M0.0%+134.9%0.235%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.3,124,100$7.78M0.0%+2.3%7.200%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.328,868$0.82M0.0%-6.0%0.758%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC11,722$29K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/15/2022Pivotal bioVenture Partners Investment Advisor LLC1,560,982$3.89M2.0%-2.3%3.597%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP25,703$0.20M0.0%-89.4%0.059%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG21,300$0.17M0.0%+45,219.1%0.049%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.3,055,037$23.74M0.1%+94.1%7.049%Search for SEC Filing on Google Icon
5/4/2022Victory Capital Management Inc.183,690$1.30M0.0%-26.6%0.424%Search for SEC Filing on Google Icon
2/25/2022AlphaCentric Advisors LLC100,000$0.42M0.1%N/A0.232%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC1,227,017$5.12M0.1%-2.2%2.849%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.1,048,956$4.37M0.0%+22.3%2.436%Search for SEC Filing on Google Icon
2/7/2022Victory Capital Management Inc.250,380$1.04M0.0%-6.5%0.581%Search for SEC Filing on Google Icon
12/3/2021Perceptive Advisors LLC1,254,607$9.94M0.1%-29.3%2.913%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.858,012$6.80M0.0%-2.0%1.992%Search for SEC Filing on Google Icon
11/15/2021Sectoral Asset Management Inc38,198$0.30M0.0%N/A0.089%Search for SEC Filing on Google Icon
11/12/2021Johnson & Johnson3,670,516$29.07M2.6%N/A8.523%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.414,256$3.28M0.0%-11.9%0.963%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.267,703$2.12M0.0%-0.7%0.622%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP154,597$1.25M0.0%+24.1%0.364%Search for SEC Filing on Google Icon
8/17/2021Perceptive Advisors LLC1,775,167$14.34M0.2%-9.0%4.181%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.875,141$7.07M0.0%+16.7%2.061%Search for SEC Filing on Google Icon
8/16/2021Perceptive Advisors LLC1,775,167$14.34M0.2%-9.0%4.181%Search for SEC Filing on Google Icon
8/16/2021Federated Hermes Inc.597,841$4.83M0.0%+5.8%1.408%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.18,221$0.15M0.0%+29.5%0.043%Search for SEC Filing on Google Icon
8/13/2021Adams Street Partners LLC2,973,744$24.03M5.0%-0.5%7.004%Search for SEC Filing on Google Icon
8/13/2021FMR LLC3,184,209$25.73M0.0%+1.5%7.500%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.470,303$3.80M0.0%-41.8%1.108%Search for SEC Filing on Google Icon
8/3/2021Victory Capital Management Inc.269,623$2.18M0.0%-5.6%0.635%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC10,726$0.12M0.0%-76.9%0.025%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.750,000$8.04M0.0%+36.4%1.766%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley76,171$0.82M0.0%+90.7%0.179%Search for SEC Filing on Google Icon
5/17/2021Perceptive Advisors LLC1,950,167$20.91M0.3%-12.8%4.593%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP124,594$1.34M0.0%+135.9%0.293%Search for SEC Filing on Google Icon
5/13/2021Federated Hermes Inc.565,000$6.06M0.0%+7.6%1.331%Search for SEC Filing on Google Icon
5/10/2021Adams Street Partners LLC2,989,644$32.05M5.1%-14.4%7.044%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.807,536$8.66M0.0%-2.8%1.903%Search for SEC Filing on Google Icon
5/7/2021Altfest L J & Co. Inc.10,139$0.11M0.0%N/A0.024%Search for SEC Filing on Google Icon
5/4/2021Victory Capital Management Inc.285,678$3.06M0.0%+59.1%0.673%Search for SEC Filing on Google Icon
3/12/2021DekaBank Deutsche Girozentrale13,000$0.16M0.0%N/A0.031%Search for SEC Filing on Google Icon
3/2/2021Norges Bank50,000$0.59M0.0%N/A0.120%Search for SEC Filing on Google Icon
2/16/2021Clough Capital Partners L P399,399$4.69M0.3%-0.8%0.957%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP23,148$0.27M0.0%-60.4%0.055%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.525,000$6.17M0.0%+2.9%1.258%Search for SEC Filing on Google Icon
2/9/2021Pivotal bioVenture Partners Investment Advisor LLC1,598,379$18.78M6.2%N/A3.831%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.830,737$9.76M0.0%+80.6%1.991%Search for SEC Filing on Google Icon
2/1/2021Victory Capital Management Inc.179,524$2.11M0.0%+18.4%0.430%Search for SEC Filing on Google Icon
12/30/2020Deerfield Management Company L.P. Series C972,046$11.68M0.2%-22.7%2.330%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley26,693$0.32M0.0%-96.0%0.064%Search for SEC Filing on Google Icon
11/12/2020Federated Hermes Inc.510,000$6.13M0.0%+59.4%1.224%Search for SEC Filing on Google Icon
11/9/2020Caas Capital Management LP58,398$0.70M0.0%-2.7%0.140%Search for SEC Filing on Google Icon
11/9/2020Victory Capital Management Inc.151,608$1.82M0.0%-17.5%0.364%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.459,918$5.53M0.0%+1.5%1.104%Search for SEC Filing on Google Icon
8/18/2020Blackstone Group Inc60,000$1.05M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/17/2020Perceptive Advisors LLC2,235,983$35.96M0.6%N/A5.367%Search for SEC Filing on Google Icon
8/14/2020Orbimed Advisors LLC3,224,770$56.34M0.8%N/A7.740%Search for SEC Filing on Google Icon
8/14/2020Canada Pension Plan Investment Board3,116,966$54.45M0.1%N/A7.481%Search for SEC Filing on Google Icon
8/14/2020Deerfield Management Company L.P. Series C1,257,000$21.96M0.6%N/A3.017%Search for SEC Filing on Google Icon
8/14/2020Point72 Hong Kong Ltd8,019$0.14M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/14/2020Point72 Europe London LLP2,000$35K0.0%N/A0.005%Search for SEC Filing on Google Icon
8/14/2020Point72 Asset Management L.P.60,000$1.05M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/14/2020TPG Group Holdings SBS Advisors Inc.2,551,794$44.58M0.8%N/A6.125%Search for SEC Filing on Google Icon
8/14/2020Tudor Investment Corp Et Al29,145$0.51M0.0%N/A0.070%Search for SEC Filing on Google Icon
8/14/2020Avidity Partners Management LP164,554$2.88M0.2%N/A0.395%Search for SEC Filing on Google Icon
8/14/2020Logos Global Management LP121,128$2.12M0.4%N/A0.291%Search for SEC Filing on Google Icon
8/14/2020Jefferies Group LLC175,800$3.07M0.0%N/A0.422%Search for SEC Filing on Google Icon
8/14/2020Alyeska Investment Group L.P.75,600$1.32M0.0%N/A0.181%Search for SEC Filing on Google Icon
8/13/2020FMR LLC3,038,998$53.09M0.0%N/A7.295%Search for SEC Filing on Google Icon
8/13/2020Federated Hermes Inc.320,000$5.59M0.0%N/A0.768%Search for SEC Filing on Google Icon
8/12/2020Johnson & Johnson Innovation JJDC Inc.3,670,516$64.12M12.6%N/A8.810%Search for SEC Filing on Google Icon
8/11/2020Monashee Investment Management LLC50,000$0.87M0.1%N/A0.120%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG5,484$96K0.0%N/A0.013%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Fusion Pharmaceuticals logo
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
Read More on Fusion Pharmaceuticals

Today's Range

Now: $2.36
Low: $2.15
High: $2.51

50 Day Range

MA: $2.44
Low: $1.98
High: $3.18

52 Week Range

Now: $2.36
Low: $1.98
High: $8.73

Volume

60,749 shs

Average Volume

58,302 shs

Market Capitalization

$105.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Fusion Pharmaceuticals?

Fusion Pharmaceuticals' top insider shareholders include:
  1. John Valliant (CEO)
  2. Steven Gannon (Director)
  3. Adams Street Partners Llc (Major Shareholder)
Learn More about top insider investors at Fusion Pharmaceuticals.

Who are the major institutional investors of Fusion Pharmaceuticals?

Fusion Pharmaceuticals' top institutional investors include:
  1. Federated Hermes Inc. — 7.09%
  2. RA Capital Management L.P. — 1.47%
  3. Point72 Asset Management L.P. — 0.69%
  4. Sofinnova Investments Inc. — 0.27%
  5. Tekla Capital Management LLC — 0.23%
  6. UBS Group AG — 0.13%
Learn More about top institutional investors of Fusion Pharmaceuticals stock.

Which institutional investors are selling Fusion Pharmaceuticals stock?

In the previous quarter, FUSN stock was sold by these institutional investors:
  1. Victory Capital Management Inc.
  2. Point72 Asset Management L.P.

Which institutional investors are buying Fusion Pharmaceuticals stock?

During the last quarter, FUSN stock was acquired by institutional investors including:
  1. RA Capital Management L.P.
  2. Tekla Capital Management LLC
  3. Federated Hermes Inc.
  4. Sofinnova Investments Inc.
  5. UBS Group AG
  6. Citadel Advisors LLC
  7. UBS Oconnor LLC
  8. Renaissance Technologies LLC